Schedule H Prescription Drug. Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Empagliflozin Tablets 25 mg
Empagliflozin 25 mg, along with approved excipients
Keep out of reach of children. Empagliflozin can cause genital fungal infections, urinary tract infections, increased urination and dehydration, particularly in elderly patients and those taking diuretics. Use only as directed by a registered medical practitioner.
Empomni-25 by EMK Omni Pharma is a prescription-based Empagliflozin Tablets 25 mg formulation used for doctor-supervised type 2 diabetes management, blood sugar control, and metabolic health support. Empomni-25 belongs to the SGLT2 inhibitor category of medicines and is commonly prescribed by healthcare professionals for patients who require support in managing high blood glucose levels, diabetes care, and long-term glycaemic control. Empomni-25 Empagliflozin 25 mg Tablets by EMK Omni Pharma are designed for patients who need physician-guided treatment for diabetes management, glucose control, metabolic wellness, and cardiovascular risk support associated with type 2 diabetes. This medicine should be used only as advised by a registered medical practitioner.
Empomni-25 may be prescribed by doctors for patients who require support in managing type 2 diabetes, high blood sugar levels, glucose imbalance, and long-term glycaemic control. It may be used as part of a complete physician-guided diabetes care plan that includes medication, diet management, regular monitoring, and lifestyle changes. Empomni-25 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood sugar control, diabetes management, and metabolic health support are required. Patients should not self-medicate, change the dosage, stop the medicine, or combine it with other diabetes medicines without consulting their doctor.
Plain-language articles on uses, how it is taken, side effects, precautions, storage and more. For information only; always follow your doctor's advice.
Diabetes CareComposition: Metformin Hydrochloride IP 500 mg (in sustained release form) and Glimepiride IP 1 mg, along with approved excipients
Dosage Strength: Metformin Hydrochloride (SR) 500 mg + Glimepiride 1 mg
Gluomni M1 by EMK Omni Pharma: prescription Metformin Hydrochloride (SR) 500 mg + Glimepiride 1 mg bilayer tablets for doctor-supervised type 2 diabetes management.
View Details
Diabetes CareComposition: Glimepiride IP 2 mg and Metformin Hydrochloride IP 500 mg as prolonged release, along with approved excipients
Dosage Strength: Glimepiride 2 mg + Metformin Hydrochloride (PR) 500 mg
Gluomni-M2 by EMK Omni Pharma is a prescription-only Glimepiride 2 mg and Metformin Hydrochloride 500 mg (Prolonged Release) Tablets IP formulation used for doctor-supervised type 2 diabetes management and blood sugar control.
View Details
Diabetes CareComposition: Sitagliptin Phosphate IP equivalent to Sitagliptin 50 mg and Metformin Hydrochloride IP 500 mg, along with approved excipients
Dosage Strength: 50 mg & 500 mg
Sitomni-M 50/500 by EMK Omni Pharma is a prescription film coated tablet containing Sitagliptin 50 mg and Metformin Hydrochloride 500 mg, used under medical supervision as part of physician-guided type 2 diabetes management.
View DetailsThis product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.